Serpin Pharma - Crunchbase Company Profile & Funding

Q: Who invested in Serpin Pharma?

Serpin Pharma is funded by Virginia Catalyst.

Q: When was the last funding round for Serpin Pharma?

Serpin Pharma closed its last funding round on obfuscated from a Grant round.

Q: How much funding has Serpin Pharma raised to date?

Serpin Pharma has raised obfuscated.

Overview

Serpin Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Serpin Pharma

CB Rank

119529

Developing New Therapeutics for Autoimmune, Inflammatory and Infectious Diseases

Founded

obfuscation

Private

Grant

Manassas, Virginia, United States

1-10

www.serpinpharma.com/

Biotechnology

Health Care

Therapeutics

Funding Rounds

Grant

OBF

obfuscation

Key People

Cohava Gelber: Executive Chairperson

Details

Legal Name

Serpin Pharma, LLC

Operating Status

Active

Company Type

For Profit

Founders

Cohava Gelber

About the Company

Serpin Pharma is a privately held, development stage biotech company with research facilities in Northern Virginia, USA. We are developing a family of first in class anti-inflammatory and immune modulating peptides with potential application in inflammatory, autoimmune and infectious diseases.

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Insight

See this Growth Insight

Serpin Pharma is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

SP16

A therapeutic peptide designed to restore immune balance by targeting the LRP1 receptor, reducing inflammation in various diseases without known adverse effects.

Acute Myocardial Infarction (AMI) treatment

In clinical trials, SP16 has shown to preserve heart function, reduce infarct size, and decrease cardiac injury biomarkers in AMI.

Research & Development

Serpin Pharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Serpin Pharma	1	obfuscated obfuscation	Virginia Catalyst	Grant
obfuscated obfuscation	Grant - Serpin Pharma	1	obfuscated obfuscation	Virginia Catalyst	Grant
obfuscated obfuscation	Grant - Serpin Pharma	1	obfuscated obfuscation	Virginia Catalyst	Grant
obfuscated obfuscation	Grant - Serpin Pharma	1	obfuscated obfuscation	Virginia Catalyst	Grant
obfuscated obfuscation	Grant - Serpin Pharma	1	obfuscated obfuscation	Virginia Catalyst	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Serpin Pharma	1	obfuscated obfuscation	Virginia Catalyst	Grant
obfuscated obfuscation	Grant - Serpin Pharma	1	obfuscated obfuscation	Virginia Catalyst	Grant
obfuscated obfuscation	Grant - Serpin Pharma	1	obfuscated obfuscation	Virginia Catalyst	Grant
obfuscated obfuscation	Grant - Serpin Pharma	1	obfuscated obfuscation	Virginia Catalyst	Grant
obfuscated obfuscation	Grant - Serpin Pharma	1	obfuscated obfuscation	Virginia Catalyst	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Virginia Catalyst	Yes	Grant - Serpin Pharma	—
Virginia Catalyst	Yes	Grant - Serpin Pharma	—
Virginia Catalyst	Yes	Grant - Serpin Pharma	—
Virginia Catalyst	Yes	Grant - Serpin Pharma	—
Virginia Catalyst	Yes	Grant - Serpin Pharma	—